Benzingaยท2025-10-01 11:58Core Insights - Investors are increasingly turning to dividend-yielding stocks during market turbulence, as these companies typically have high free cash flows and offer substantial dividend payouts [1] Company Summaries GSK plc (NYSE:GSK) - Dividend Yield: 4.13% - Jefferies analyst Peter Welford downgraded the stock from Buy to Hold on Nov. 12, 2024, with an accuracy rate of 57% [7] - Guggenheim analyst Seamus Fernandez downgraded the stock from Buy to Neutral on Oct. 31, 2024, with an accuracy rate of 73% [7] - Recent News: Luke Miels appointed as CEO Designate, effective Jan. 1, 2026 [7] DENTSPLY SIRONA Inc (NASDAQ:XRAY) - Dividend Yield: 5.04% - UBS analyst Kevin Caliendo maintained a Buy rating but reduced the price target from $25 to $24 on Aug. 8, 2025, with an accuracy rate of 67% [7] - Stifel analyst Jonathan Block maintained a Hold rating and cut the price target from $19 to $17 on Aug. 8, 2025, with an accuracy rate of 71% [7] - Recent News: Decision to retain Wellspect Healthcare after a strategic review on Sept. 8 [7] Bristol-Myers Squibb Company (NYSE:BMY) - Dividend Yield: 5.62% - Citigroup analyst Andrew Baum maintained a Neutral rating and lowered the price target from $51 to $47 on Aug. 1, 2025, with an accuracy rate of 69% [7] - Morgan Stanley analyst Terence Flynn maintained an Underweight rating and reduced the price target from $36 to $34 on July 10, 2025, with an accuracy rate of 63% [7] - Recent News: Announced results from the Phase 3 EXCALIBER-RRMM study on Sept. 23, evaluating iberdomide in combination with standard therapies for multiple myeloma [7]